Lanlan Si

机构：Guangzhou Medical University

发表论文 38 篇 · 总被引 491 次 · h-index 13

代表论文

• Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model (2018 · Antiviral Research · 被引 35)
• Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S‐gene mutants isolated from individuals with occult HBV infection (2017 · Journal of Medical Virology · 被引 28)
• Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice (2019 · Emerging Microbes & Infections · 被引 24)
• Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs (2017 · Oncotarget · 被引 24)
• Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model (2021 · Frontiers in Pharmacology · 被引 23)
• The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: Analysis of a large cohort of Chinese patients (2020 · Journal of Clinical Virology · 被引 21)